Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Antonia M S, Müller"'
Autor:
Christian Koch, Patrick Roth, Juliane Fleischer, Todor Popov, Karl Frontzek, Bettina Schreiner, Markus G. Manz, Simone Unseld, Antonia M. S. Müller, Norman F. Russkamp
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background Immune effector cell-associated neurotoxicity syndrome (ICANS) is a common adverse event of CD19-directed chimeric antigen receptor (CAR) T cell therapy. Other neurological adverse events, however, have not methodically been described and
Externí odkaz:
https://doaj.org/article/a2020bdc501145f7a8e17396c48a49e8
Autor:
Wiebke Rösler, Andrea Bink, Marina Bissig, Lukas Imbach, Ewerton Marques Maggio, Markus G. Manz, Thomas Müller, Patrick Roth, Elisabeth Rushing, Corinne Widmer, Thorsten Zenz, Seraina von Moos, Antonia M. S. Müller
Publikováno v:
HemaSphere, Vol 6, Iss 7, p e733 (2022)
Externí odkaz:
https://doaj.org/article/e738f2730c664befb16db39f17aa04bc
Autor:
Josefine Ruder, Jordan Rex, Simon Obahor, María José Docampo, Antonia M. S. Müller, Urs Schanz, Ilijas Jelcic, Roland Martin
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, in which autoreactive T and B cells play important roles. Other lymphocytes such as NK cells and innate-like T cells appear to be involved as well. To name a few examples
Externí odkaz:
https://doaj.org/article/145f4d2d4c0b49d7aea996ae41029e2e
Publikováno v:
Biotechnology Advances. 58:107917
Chimeric antigen receptor (CAR) technology, and CAR-T cells in particular, have emerged as a new and powerful tool in cancer immunotherapy since demonstrating efficacy against several hematological malignancies. However, despite encouraging clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586ab6bf23b541a5f026428326b6d16d
https://doi.org/10.1016/j.biotechadv.2022.107917
https://doi.org/10.1016/j.biotechadv.2022.107917
Autor:
Alexander, Ring, Antonia M S, Müller
Publikováno v:
Praxis. 108(6)
Chemotherapy-Free Treatment of Hematological Neoplasias: Dream or Reality?
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::52a47b12c12ed30d48e018f323e0b1a5
https://pubmed.ncbi.nlm.nih.gov/31039712
https://pubmed.ncbi.nlm.nih.gov/31039712
Autor:
Antonia M. S. Müller, Alexander Ring
Zusammenfassung. Hämatologische Neoplasien sind eine heterogene Gruppe von Erkrankungen, denen eine klonale Expansion unreifer, dysfunktionaler Blutzellpopulationen zugrunde liegt. Durch Chemotherapie kann in einem Teil der Patienten eine Langzeitre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36cc75a7f398303a6e598dbb5012ca16
https://www.zora.uzh.ch/id/eprint/184902/
https://www.zora.uzh.ch/id/eprint/184902/
Autor:
Marc, Wehrli, Elisabeth, Oppliger Leibundgut, Heinrich H, Gattiker, Markus G, Manz, Antonia M S, Müller, Jeroen S, Goede
Publikováno v:
The oncologist. 22(4)
This brief communication reports on a patient with an exceedingly rare "8p11 (eight-p-eleven) myeloproliferative syndrome" (EMS) with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83a5d28a12f93e0648d1750a23e4faac
https://pubmed.ncbi.nlm.nih.gov/28242791
https://pubmed.ncbi.nlm.nih.gov/28242791
Autor:
Silke C. Hofmann, Kristin Technau, Michael Lübbert, Leena Bruckner-Tuderman, Antonia M. S. Müller
Publikováno v:
Journal of the American Academy of Dermatology. 56:S68-S72
Hypereosinophilic syndrome is a myeloproliferative disorder defined by unexplained, persistent hypereosinophilia with cutaneous or systemic involvement. We describe a patient with coexistence of hypereosinophilic syndrome and bullous pemphigoid. Trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5ccb98d3e8fc1f23d9b5aa92b2ee64d
https://doi.org/10.1016/j.jaad.2006.02.059
https://doi.org/10.1016/j.jaad.2006.02.059
Autor:
Antonia M S, Müller, Mareike, Florek
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 201
The hypomethylating agent 5-Azacytidine epigenetically modulates various genes, including tumor suppressor genes. For many years, the "new agent", which was first discovered in the 1960s, remained fairly unobtrusive in the rank of salvage treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff1843f0c68316fd8d0715c9a708c1d7
https://pubmed.ncbi.nlm.nih.gov/24756801
https://pubmed.ncbi.nlm.nih.gov/24756801
Autor:
Antonia M S, Müller, Matthias J, Betz, Jan, Kromeier, Nadir A, Ghanem, Annette, Geibel, Andreas, Imdahl, Alex P, Frydrychowicz
Publikováno v:
Circulation. 114(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5b979bd3b03fab03060713fefb24c2d1
https://pubmed.ncbi.nlm.nih.gov/16818823
https://pubmed.ncbi.nlm.nih.gov/16818823